Anti-HER2 monoclonal antibody based-radioimmunoconjugates: Assessment of the chelating agent influence. - Miranda ACC; Durante ACR; Fuscaldi LL; Barbezan AB; de Lima CR; Perini E; de Araújo EB (Bioorganic & medicinal chemistry, 2021)